GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Nickel, Nils ^a   Jonigk, Danny ^a   Kempf, Tibor ^a   Bockmeyer, Clemens L ^a   Maegel, Lavinia ^a   Rische, Johanna ^a   Laenger, Florian ^a   Lehmann, Ulrich ^a   Sauer, Clemens ^a   Greer, Mark ^a   Welte, Tobias ^a   Hoeper, Marius M ^a   Golpon, Heiko A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; RECOMBINANT PROTEIN; GDF15 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REAL TIME POLYMERASE CHAIN REACTION; SHEAR STRESS; UPREGULATION; ANALYSIS OF VARIANCE; ANGIOGENESIS; CASE CONTROL STUDY; CELL CULTURE; CELL HYPOXIA; GENETICS; IDIOPATHIC PULMONARY HYPERTENSION; LUNG; MECHANICAL STRESS; METABOLISM; MICRODISSECTION; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; VASCULARIZATION;

ANALYSIS OF VARIANCE; APOPTOSIS; CASE-CONTROL STUDIES; CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; LUNG; MICRODISSECTION; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS, MECHANICAL; TIME FACTORS; UP-REGULATION;

EID: 79955668213     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-62     Document Type: Article

References (41)

1. Bottner M, Laaff M, Schechinger B, Rappold G, Unsicker K, Suter-Crazzolara C. Charac-terization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1). Gene 1999, 237:105-111. 10.1016/S0378-1119(99)00309-1, 10524241.
2. Strelau J, Bottner M, Lingor P, Suter-Crazzolara C, Galter D, Jaszai J, et al. GDF-15/MIC-1 a novel member of the TGF-beta superfamily. J Neural Transm Suppl 2000, 273-276.
3. Bella AJ, Lin G, Lin CS, Hickling DR, Morash C, Lue TF. Nerve growth factor modulation of the cavernous nerve response to injury. J Sex Med 2009, 6:347-352. 10.1111/j.1743-6109.2008.01194.x, 2706280, 19267859.
4. Koniaris LG. Induction of MIC-1/growth differentiation factor-15 following bile duct injury. J Gastrointest Surg 2003, 7:901-905. 10.1007/s11605-003-0037-5, 14592665.
5. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG. Growth differen-tiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 2005, 23:543-548.
6. Zimmers TA, Jin X, Hsiao EC, Perez EA, Pierce RH, Chavin KD, et al. Growth differen-tiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. J Surg Res 2006, 130:45-51. 10.1016/j.jss.2005.07.036, 16154591.
7. Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, et al. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 2004, 318:325-333. 10.1007/s00441-004-0986-3, 15459768.
8. Kempf T, Wollert KC. Growth-differentiation factor-15 in heart failure. Heart Fail Clin 2009, 5:537-547. 10.1016/j.hfc.2009.04.006, 19631178.
9. Ferrari N, Pfeffer U, Dell'Eva R, Ambrosini C, Noonan DM, Albini A. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Clin Cancer Res 2005, 11:4610-4619. 10.1158/1078-0432.CCR-04-2210, 15958647.
10. Lamouille S, Mallet C, Feige JJ, Bailly S. Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 2002, 100:4495-4501. 10.1182/blood.V100.13.4495, 12453878.
11. Secchiero P, Corallini F, Gonelli A, Dell'Eva R, Vitale M, Capitani S, et al. Antiangi-ogenic activity of the MDM2 antagonist nutlin-3. Circ Res 2007, 100:61-69. 10.1161/01.RES.0000253975.76198.ff, 17138942.
12. Huh SJ, Chung CY, Sharma A, Robertson GP. Macrophage inhibitory cytokine-1 regu-lates melanoma vascular development. Am J Pathol 2010, 176:2948-2957. 10.2353/ajpath.2010.090963, 20431030.
13. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54:S43-S54. 10.1016/j.jacc.2009.04.012, 19555858.
14. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54:S20-S31. 10.1016/j.jacc.2009.04.018, 2790324, 19555855.
15. Tuder RM, Voelkel NF. Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion. Am J Pathol 2001, 159:382-383. 10.1016/S0002-9440(10)61705-1, 1850393, 11438486.
16. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2008, 118:2372-2379. 10.1172/JCI33452, 2439479, 18596905.
17. Nickel N, Kempf T, Tapken H, Tongers J, Laenger F, Lehmann U, et al. Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2008, 178:534-541. 10.1164/rccm.200802-235OC, 18565955.
18. Meadows CA, Risbano MG, Zhang L, Geraci MW, Tuder RM, Collier DH, et al. In-creased Expression of Growth Differentiation Factor-15 in Scleroderma-Associated Pulmonary Arterial Hypertension. Chest 2010,
19. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958, 18:533-547.
20. Hromas R, Hufford M, Sutton J, Xu D, Li Y, Lu L. PLAB, a novel placental bone mor-phogenetic protein. Biochim Biophys Acta 1997, 1354:40-44.
21. Liu T, Bauskin AR, Zaunders J, Brown DA, Pankhurst S, Russell PJ, et al. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 2003, 63:5034-5040.
22. Theophile K, Jonigk D, Kreipe H, Bock O. Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR. Diagn Mol Pathol 2008, 17:101-106. 10.1097/PDM.0b013e318163f26e, 18382351.
23. Krump-Konvalinkova V, Bittinger F, Unger RE, Peters K, Lehr HA, Kirkpatrick CJ. Generation of human pulmonary microvascular endothelial cell lines. Lab Invest 2001, 81:1717-1727.
24. Azizan A, Sweat J, Espino C, Gemmer J, Stark L, Kazanis D. Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus. J Virol Methods 2006, 138:211-217. 10.1016/j.jviromet.2006.08.010, 17034872.
25. Santos MI, Fuchs S, Gomes ME, Unger RE, Reis RL, Kirkpatrick CJ. Response of micro- and macrovascular endothelial cells to starch-based fiber meshes for bone tissue engineering. Biomaterials 2007, 28:240-248. 10.1016/j.biomaterials.2006.08.006, 16945411.
26. Huss JM, Levy FH, Kelly DP. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid × receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem 2001, 276:27605-27612. 10.1074/jbc.M100277200, 11371554.
27. Topper JN, Cai J, Falb D, Gimbrone MA. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 1996, 93:10417-10422. 10.1073/pnas.93.19.10417, 38399, 8816815.
28. Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclero-sis. JAMA 1999, 282:2035-2042. 10.1001/jama.282.21.2035, 10591386.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63. 10.1016/0022-1759(83)90303-4, 6606682.
30. Golpon HA, Fadok VA, Taraseviciene-Stewart L, Scerbavicius R, Sauer C, Welte T, et al. Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J 2004, 18:1716-1718.
31. Korff T, Augustin HG. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci 1999, 112:3249-3258.
32. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 2006, 98:351-360. 10.1161/01.RES.0000202805.73038.48, 16397141.
33. Kempf T, Horn-Wichmann R, Brabant G, Peter T, Allhoff T, Klein G, et al. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin Chem 2007, 53:284-291.
34. Bottner M, Suter-Crazzolara C, Schober A, Unsicker K. Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 1999, 297:103-110. 10.1007/s004410051337, 10398887.
35. ten DP, Arthur HM. Extracellular control of TGFbeta signalling in vascular develop-ment and disease. Nat Rev Mol Cell Biol 2007, 8:857-869.
36. Jamison BM, Michel RP. Different distribution of plexiform lesions in primary and secondary pulmonary hypertension. Hum Pathol 1995, 26:987-993. 10.1016/0046-8177(95)90088-8, 7672799.
37. Tuder RM, Cool CD, Yeager M, Taraseviciene-Stewart L, Bull TM, Voelkel NF. The pathobiology of pulmonary hypertension. Endothelium. Clin Chest Med 2001, 22:405-418. 10.1016/S0272-5231(05)70280-X, 11590837.
38. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth fac-tor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest 1994, 93:1172-1178. 10.1172/JCI117070, 294068, 8132757.
39. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994, 144:275-285. 1887146, 7508683.
40. Stevens T. Molecular and cellular determinants of lung endothelial cell heterogene-ity. Chest 2005, 128:558S-564S. 10.1378/chest.128.6_suppl.558S, 16373825.
41. Dimmeler S, Assmus B, Hermann C, Haendeler J, Zeiher AM. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res 1998, 83:334-341.